International Journal of Diabetes in Developing Countries

Scope & Guideline

Advancing diabetes research for a healthier tomorrow.

Introduction

Immerse yourself in the scholarly insights of International Journal of Diabetes in Developing Countries with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0973-3930
PublisherSPRINGER INDIA
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2001 to 2002, from 2006 to 2024
AbbreviationINT J DIABETES DEV C / Int. Diabetes Dev. Ctries.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI 110 001, INDIA

Aims and Scopes

The International Journal of Diabetes in Developing Countries focuses on addressing the challenges and advancements in diabetes care, particularly in developing regions. It aims to disseminate research that contributes to the understanding, prevention, and management of diabetes and its complications, with a strong emphasis on local epidemiology, culturally relevant interventions, and innovative healthcare solutions.
  1. Diabetes Epidemiology and Prevalence:
    Research focusing on the prevalence, risk factors, and demographic characteristics of diabetes in various populations, particularly in developing countries.
  2. Innovative Treatment Approaches:
    Studies exploring new treatment modalities, including pharmacological interventions, lifestyle modifications, and technological advancements in diabetes management.
  3. Diabetes Complications and Comorbidities:
    Investigations into the complications of diabetes such as retinopathy, neuropathy, nephropathy, and their associated comorbid conditions, with a focus on clinical profiles and outcomes.
  4. Patient Education and Self-Management:
    Research aimed at improving diabetes self-care practices among patients, including educational interventions and their impact on health outcomes.
  5. Cultural and Socioeconomic Factors:
    Exploration of how cultural beliefs, socioeconomic status, and healthcare access influence diabetes management and outcomes in different communities.
  6. Public Health Initiatives:
    Evaluating public health strategies aimed at diabetes prevention and control, including screening programs and community-based interventions.
Recent publications in the journal indicate a shift towards innovative and technology-driven approaches to diabetes management, reflecting current trends and emerging research areas that are gaining attention.
  1. Digital Health and Telemedicine:
    An increasing number of studies are exploring the use of digital health technologies and telemedicine for diabetes management, particularly in the context of the COVID-19 pandemic.
  2. Artificial Intelligence and Machine Learning:
    Research utilizing AI and machine learning to improve diabetes care, including predictive modeling and automated systems for monitoring and treatment.
  3. Integrated Care Models:
    Emerging themes around integrated care approaches that combine diabetes management with other health services, focusing on holistic patient care.
  4. Personalized Medicine and Genomics:
    An upward trend in research on personalized medicine, including genetic factors influencing diabetes and tailored treatment strategies.
  5. Mental Health and Diabetes:
    A growing recognition of the psychological aspects of diabetes management, with increasing research on diabetes-related distress and mental health interventions.

Declining or Waning

While the journal has consistently focused on various aspects of diabetes care, certain themes appear to be declining in prominence, possibly due to shifts in research focus or evolving health priorities.
  1. Traditional Dietary Interventions:
    Research on basic dietary interventions for diabetes management has seen a decline, as more advanced nutritional approaches and personalized medicine gain traction.
  2. Basic Pharmacological Studies:
    There is a noticeable decrease in studies solely focusing on the pharmacodynamics of traditional diabetes medications, as newer classes of drugs and combination therapies are becoming more prominent.
  3. Generalized Diabetes Management Guidelines:
    The emphasis on generic diabetes management guidelines is waning, with a growing focus on individualized and context-specific approaches to care.

Similar Journals

Journal of Diabetes and Metabolic Disorders

Leading the Charge in Metabolic Disorder Research
Publisher: SPRINGER INT PUBL AGISSN: Frequency:

The Journal of Diabetes and Metabolic Disorders, published by SPRINGER INT PUBL AG, is a premier academic journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. With an E-ISSN of 2251-6581, this journal plays a crucial role in disseminating high-quality research findings from 2012 to 2024, serving as a valuable resource for researchers, practitioners, and students alike. Notably, it has achieved impressive rankings, being placed in the Q2 quartile for Internal Medicine and Q3 for Endocrinology, Diabetes, and Metabolism in 2023, reflecting its influence within the scientific community. The Journal’s commitment to open access ensures that its comprehensive articles, encompassing topics from metabolic disorders to novel therapeutic approaches, are readily available to a global audience. Position yourself at the forefront of medical advancements—contribute to and benefit from the pivotal research presented in this journal.

DIABETES CARE

Transforming knowledge into diabetes care solutions.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

Diabetologie und Stoffwechsel

Empowering the Future of Diabetes Research and Treatment
Publisher: GEORG THIEME VERLAG KGISSN: 1861-9002Frequency: 6 issues/year

Diabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.

Current Diabetes Reports

Elevating the standard of care in diabetes and endocrinology.
Publisher: CURRENT MEDICINE GROUPISSN: 1534-4827Frequency: 12 issues/year

Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.

Diabetes Mellitus

Innovating therapeutic strategies for diabetes management.
Publisher: ENDOCRINOLOGY RESEARCH CENTREISSN: 2072-0351Frequency: 4 issues/year

Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.

Canadian Journal of Diabetes

Exploring the frontiers of endocrinology and diabetes.
Publisher: ELSEVIERISSN: 1499-2671Frequency: 6 issues/year

Canadian Journal of Diabetes is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the understanding and management of diabetes and its associated conditions. Established in 2002, this journal serves as an essential resource for researchers, healthcare professionals, and students interested in the field of endocrinology, diabetes, and metabolism, boasting a commendable Impact Factor that signifies its influence in the academic community. With a focus on high-quality research articles, comprehensive reviews, and insightful commentary, the journal's scope encompasses clinical and experimental studies that address the challenges of diabetes care and prevention. Currently ranked in the Q2 category across multiple relevant categories, including Endocrinology and Medicine, the Canadian Journal of Diabetes is crucial for those seeking to stay at the forefront of diabetes research and practice. The journal is indexed in prestigious databases, making it easily accessible to the global academic community. Located in Amsterdam, Netherlands, it reflects the publisher's commitment to promoting innovation and collaboration in medical research.

British Journal of Diabetes

Illuminating the path to better diabetes outcomes.
Publisher: ASSOC BRITISH CLINICAL DIABETOLOGISTSISSN: 2397-6233Frequency: 2 issues/year

The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.

DIABETOLOGIA

Connecting researchers to the forefront of diabetes science.
Publisher: SPRINGERISSN: 0012-186XFrequency: 12 issues/year

DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.

BMJ Open Diabetes Research & Care

Fostering groundbreaking discoveries in diabetes research.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 6 issues/year

BMJ Open Diabetes Research & Care is a premier open access journal published by the BMJ PUBLISHING GROUP, dedicated to advancing the field of diabetes research and care. With an impressive impact factor and positioned in the Q1 category of Endocrinology, Diabetes and Metabolism, this journal serves as a vital resource for researchers, clinicians, and healthcare professionals striving to improve diabetes management and treatment strategies. Since its inception in 2014, the journal has provided an accessible platform for high-quality, peer-reviewed research, ensuring global outreach and dissemination of groundbreaking findings in diabetes care. With Scopus ranking it at #35 out of 244 in its field, reflecting an 85th percentile ranking, BMJ Open Diabetes Research & Care remains committed to fostering innovation and discourse within the diabetes community. This journal not only publishes original research articles but also invites systematic reviews, clinical studies, and comprehensive reviews, aiming to address the pressing challenges faced in diabetes care today.

DIABETES & METABOLISM

Transforming Insights into Metabolic Disease Solutions
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.